Lin Patrick bought PCSA

January 1, 2026 · Form 4 insider transaction

Lin Patrick bought 193 shares of Processa Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 34 days after the transaction.

Direction
Acquired (buy-side)
Shares
193
Price
$0.00
Total value
N/A
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 1, 2026
Filing dateFebruary 4, 2026
Shares owned after1,753
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Distribution of vested restricted shares.

View the original Form 4 on SEC EDGAR